![Bradley Hodges](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Hodges
Private Equity Investor at
CureDuchenne Ventures LLC
Profile
Bradley Hodges has founded Prothelia, Inc. in 2007, where he holds the title of Chief Scientific Officer.
Currently, he is a Partner at CureDuchenne Ventures LLC since 2022.
Bradley Hodges active positions
| Companies | Position | Start |
|---|---|---|
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Private Equity Investor | 2022-04-30 |
Former positions of Bradley Hodges
| Companies | Position | End |
|---|---|---|
Prothelia, Inc.
 Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Finance |
Prothelia, Inc.
Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
- Stock Market
- Insiders
- Bradley Hodges
